| Fund Name | Location |
| Beijing UTour International Travel Service Co | China, Shanghai |
| Draper Cygnus II | Argentina, Buenos Aires, Distrito Federal |
| EDF Ventures | Ann Arbor, Michigan, United States |
| Huayi Ziben | China, Jiading District |
| Klaus Eckstein KG | - |
| Kunshan Zhouyuan Electronics | China, Jiangsu, Suzhou |
| Maxygen | California, Redwood City, United States |
| Medcaptain | China, Guangdong, Shenzhen |
| Neon Capital | - |
| Ningbo Daxiejun Shaoyong chi Touzi Hehuo Qiye (Youxian Hehuo) | China, Ningbo, Zhejiang |
| Ningbo Meishan Free Trade Port Zone Huazanheng Investment Management | China, Ningbo, Zhejiang |
| Oliver Wyman | New York, New York, United States |
| Reddere Invest | - |
| RSVP Capital | Ann Arbor, Michigan, United States |
| Shoushan Caifu | - |
| Smarter Capital | Australia, Saint Leonards, Victoria |
| Telluride Venture Accelerator | Colorado, Telluride, United States |
| TL Asset Management | - |
| Xinhe Taidao Investment Management | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Livzon Mabpharm | 27 Jun 2018 | Xiangzhou District, Guangdong Province, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Livzon Mabpharm | 27 Jun 2018 | Xiangzhou District, Guangdong Province, China |
